West Pharmaceutical Services (WST)

Cost of Revenue

$543.10M

Quarterly · Period ending: · USD

WST logo

WST Cost of Revenue

Latest reported$543.10M
WST Quarterly Cost of Revenue ($0.00 → $543.10M)
High-resolution chart · PNG

WST cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
543,100,000
548,500,000
501,100,000
510,800,000
493,000,000
465,500,000
474,100,000
481,700,000
470,700,000
464,000,000
453,100,000
458,000,000
462,000,000
445,300,000
445,000,000
418,900,000
451,800,000
434,900,000
436,400,000
418,100,000
407,700,000
398,300,000
368,800,000
357,400,000
332,400,000
324,300,000
317,500,000
308,500,000
311,900,000
296,800,000
289,400,000
296,200,000
305,200,000
280,900,000
286,600,000
272,800,000
272,500,000
253,600,000
259,100,000
255,600,000
254,700,000
238,800,000
240,100,000
236,200,000
241,500,000
226,200,000
240,100,000
246,000,000
247,100,000
240,400,000
236,100,000
236,300,000
233,600,000
227,700,000
224,000,000
213,400,000
226,100,000
215,200,000
210,100,000
212,200,000
223,300,000
207,400,000
198,800,000
196,700,000
198,600,000
192,500,000
209,500,000
187,200,000
182,300,000
173,100,000
175,200,000
190,200,000
195,700,000
187,200,000
185,600,000
178,400,000
187,000,000
177,200,000
166,300,000
159,600,000
169,700,000
155,900,000
143,900,000
137,800,000
122,400,000
103,100,000
98,800,000
98,600,000
95,300,000
93,000,000
84,200,000
84,300,000
85,000,000
81,400,000
74,900,000
78,200,000
76,700,000
72,300,000
24,800,000
84,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.